The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC).
 
Nai-Jung Chiang
No Relationships to Disclose
 
Kelvin K. Tsai
No Relationships to Disclose
 
Jen-Shi Chen
No Relationships to Disclose
 
Shih-Hung Yang
No Relationships to Disclose
 
Chiun Hsu
No Relationships to Disclose
 
Yan-Shen Shan
No Relationships to Disclose
 
Li-Tzong Chen
Research Funding - Merck Serono; Merck Serono (Inst); Merrimack; Merrimack (Inst); MSD; MSD (Inst); Novartis; Novartis (Inst); Ono Pharmaceutical; Ono Pharmaceutical (Inst); PharmaEngine; PharmaEngine (Inst); Sanofi; Sanofi (Inst); TTY Biopharm; TTY Biopharm (Inst)